Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
January 14, 2019 1:52 PM 2 min read

Credit Suisse Expects Northrop Grumman To Outperform

by Dave Maher
Follow

ArticleFeaturedTickersList12345!!!

Northrop Grumman Corporation (NYSE:NOC) saw its stock battered last year - and now it's a good time to buy, according to Credit Suisse.

The Analyst

Credit Suisse analyst Robert Spingarn upgraded Northrop Grumman to Outperform from Neutral, with a price target lowered from $311 to $302.

The Thesis

Northrop looks like a good value because it’s stock dropped more than 20 percent last year – after having been overvalued in Spingarn’s opinion. The sell-off has created a buying opportunity for what used to be one of the more expensive defense stocks, Spingarn said.

“With 2018’s market correction, NOC now has one of the most well supported valuations among the defense primes,” he wrote in a note to investors on Monday.

Falls Church, Va.-based Northrop is well-positioned in the country’s national security scheme, with its cutting-edge tech focus more in line with the direction the American military is moving than it has been in the past, Spingarn wrote. Credit Suisse cited the company’s Common Infrared Countermeasures program as an example of a relatively small, but significant high-tech product it expects to see revenue ramp on over the next several years. The CIRCM is a hardware package for military aircraft that blocks incoming heat-seeking missiles.

Related Link: Government Shutdown Impacts U.S. Airline Industry

Among the other projects that will likely lead to strong revenue growth in coming years are the F-35 aircraft, on which Northrop Grumman is a key supplier and the Air Force’s B-21 Raider stealth bomber, which Spingarn said is one of Northrop’s “most compelling longer-term growth opportunities.”

It also could see a chance to get into new defense work lines resulting from its 2017 acquisition of Orbital ATK. New types of work that might be good for Northrop Grumman investors because of that acquisition could include work in space technology, including launch vehicles and propulsion, as well as missiles and missile defense systems, the Credit Suisse note said.

Price Action

Northrop Grumman's stock was up 1.6 percent to $260.25 at time of publication.

Photo courtesy of Northrop Grumman.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorUpgradesAnalyst RatingsCredit Suisse
NOC Logo
NOCNorthrop Grumman Corp
$697.430.13%
Overview
NOC Logo
NOCNorthrop Grumman Corp
$697.430.13%
Overview
Comments
Loading...